Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Australian Pharmaceutical Industries Releases 2020 AGM - CEO Managing Director Address to Shareholders

20 Jan 2021  |  14:59:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: 2020 AGM- CEO & Managing Director Address to Shareholders

Australian Pharmaceutical Industries released CEO Managing Director address to shareholders in relation to the AGM of the year 2020. The Company reported a total revenue of $4 billion, representing a 0.2% increase over the prior year. The underlying EBIT was $56.3 million, down 40.1% on the prior year. This decline was largely due to the impact COVID-19 had on retail businesses. The underlying NPAT was $32.5 million, representing a 42.6% decrease on the prior year. Underlying return on capital employed was down to 10.35 per cent from 16.29% in the FY2019. This was driven by the COVID disruptions to due to Company's retail network. In the FY2020 the Company opened 15 clinics, taking the total number to 67 at year-end.

Please click here for full details

See more ASX300 News Announcements